ABUS - Arbutus Biopharma GAAP EPS of -$0.10 beats by $0.01 revenue of $1.53M misses by $1.19M
2024-05-02 07:33:05 ET
More on Arbutus Biopharma
- Moderna Investors Should Beware Patent-Dispute Fallout
- Arbutus Biopharma: The Markman Win Is A Good Milestone But Uncertainty Remains
- Arbutus Biopharma Corporation (ABUS) Q4 2023 Earnings Call Transcript
- Arbutus Biopharma Q1 2024 Earnings Preview
- Arbutus Biopharma jumps after claim construction order in patent fight with Moderna